Omega Fund Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,018,737
Closed -$109M 16
2022
Q4
$109M Hold
3,018,737
36.57% 1
2022
Q3
$45.4M Hold
3,018,737
16.64% 2
2022
Q2
$40.4M Hold
3,018,737
12.9% 3
2022
Q1
$58.2M Hold
3,018,737
11.91% 3
2021
Q4
$71.6M Hold
3,018,737
10.12% 3
2021
Q3
$60.5M Buy
+3,018,737
New +$64.8M 6.78% 5

Omega Fund Management's IMGO Position: Q1 2023 in Review

Omega Fund Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 3,018,737 shares — an estimated $109M sold.

Omega Fund Management first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $109M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Omega Fund Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Omega Fund Management sold 3,018,737 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $109M.
  • Omega Fund Management first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
  • Omega Fund Management's Imago BioSciences, Inc. Common stock position peaked at $109M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Omega Fund Management's 13F filing for Q1 2023, filed 15 May 2023.